Biochemical
Cetuximab 100mg/20ml Injection(Bulk solution can be supplied commercially as well)
AP-4
Description
Cetuximab is an epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions.
Both the finished product of Cetuximab and bulk solution can be supplied commercially!
Apino Pharma focuses on phamraceutical industry especially APIs and Key Intermediates as well as full service from R&D stage to commercial stage with the concept of “Added Value, Profession, Innovation”. We strictly follow the principle “Quality First” by supplying most reliable quality, professional service and reasonable price for the customers.
Apino supply below featured products and professional service:
1.APIs (Mainly new generic APIs and Biosimilar products-Peptides, Anti-cancer mabs, Insulin…etc.)
2.Intermediates
3.Finished products
4.Custom Synthesis Service
Read More
Apino Pharma Co., Ltd.
API, Intermediates, Peptides
Read MoreContact
Tel: +8613265879427
Address:
413, Jinrun Building, No.6019 Shennan Road, Tianan Community, Shatou Street, Futian District, Shenzhen City, China, Guangdong, China, 518000
